Results 91 to 100 of about 1,396 (156)

Factors associated to adherence to different treatment schemes with meglumine antimoniate in a clinical trial for cutaneous leishmaniasis. [PDF]

Rev Inst Med Trop Sao Paulo, 2014
Ribeiro MN, Pimentel MI, Schubach Ade O, Oliveira Rde V, Teixeira JL, Leite MP, Fonseca M, Santos GP, Salgueiro MM, Ferreira e Vasconcellos Ede C, Lyra MR, Saheki MN, Valete-Rosalino CM.   +12 more
europepmc   +1 more source

Tratamento da Leishmaniose cutânea: associação de uma droga leishmanicida com imunoterapia tópica

, 2018
Objetivo: Avaliar a resposta terapêutica e produção de citocinas inflamatórias de pacientes com leishmaniose cutânea (LC) no tratamento com uma droga leishmanicida associada a imunoterapia tópica. Métodos: 1. No 1º ensaio clínico, 36 pacientes com LC e
Prates, Fernanda Ventin de Oliveira
core  

Leg ulcers in sickle cell disease patients. [PDF]

J Vasc Bras, 2020
Granja PD, Quintão SBM, Perondi F, de Lima RBF, Martins CLM, Marques MA, de Oliveira JCP.   +6 more
europepmc   +1 more source

SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023. [PDF]

Arq Bras Cardiol, 2023
Marin-Neto JA, Rassi A, Oliveira GMM, Correia LCL, Ramos Júnior AN, Luquetti AO, Hasslocher-Moreno AM, Sousa AS, Paola AAV, Sousa ACS, Ribeiro ALP, Correia Filho D, Souza DDSM, Cunha-Neto E, Ramires FJA, Bacal F, Nunes MDCP, Martinelli Filho M, Scanavacca MI, Saraiva RM, Oliveira Júnior WA, Lorga-Filho AM, Guimarães AJBA, Braga ALL, Oliveira AS, Sarabanda AVL, Pinto AYDN, Carmo AALD, Schmidt A, Costa ARD, Ianni BM, Markman Filho B, Rochitte CE, Macêdo CT, Mady C, Chevillard C, Virgens CMBD, Castro CN, Britto CFPC, Pisani C, Rassi DDC, Sobral Filho DC, Almeida DR, Bocchi EA, Mesquita ET, Mendes FSNS, Gondim FTP, Silva GMSD, Peixoto GL, Lima GG, Veloso HH, Moreira HT, Lopes HB, Pinto IMF, Ferreira JMBB, Nunes JPS, Barreto-Filho JAS, Saraiva JFK, Lannes-Vieira J, Oliveira JLM, Armaganijan LV, Martins LC, Sangenis LHC, Barbosa MPT, Almeida-Santos MA, Simões MV, Yasuda MAS, Moreira MDCV, Higuchi ML, Monteiro MRCC, Mediano MFF, Lima MM, Oliveira MT, Romano MMD, Araujo NNSL, Medeiros PTJ, Alves RV, Teixeira RA, Pedrosa RC, Aras Junior R, Torres RM, Povoa RMDS, Rassi SG, Alves SMM, Tavares SBDN, Palmeira SL, Silva Júnior TLD, Rodrigues TDR, Madrini Junior V, Brant VMDC, Dutra WO, Dias JCP.   +91 more
europepmc   +1 more source

Azitromicina para tratamento de leishmaniose cutânea em Manaus, AM, Brasil

, 2007
Para avaliar a eficácia da azitromicina na leishmaniose cutânea, foi realizado ensaio clínico em Manaus, Amazonas, onde o agente etiológico predominante é a Leishmania (Viannia) guyanensis.
Teixeira, Alan César, Paes, Marcilene Gomes, Prata, Aluízio, Silva-Vergara, Mario León, Guerra, Jorge de Oliveira   +4 more
core  

Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024. [PDF]

Epidemiol Serv Saude
Silva SN, Saliba MF, Ribeiro LR, Cota G.
europepmc   +1 more source

Factors associated with deaths due to visceral leishmaniasis among children at a hospital in the southwest of Maranhão state: a cross-sectional study, Imperatriz, 2010-2021. [PDF]

Epidemiol Serv Saude
Teixeira MMP, Santos DFD, Barros EA, Santos LHD, Siqueira LS, Pascoal LM, Costa ACPJ, Santos Neto M.   +7 more
europepmc   +1 more source

Ocurrence of Nyssomyia intermedia (Diptera: Psychodidae) in intradomiciliary environments: a potential vector of american cutaneous leishmaniasis in Montezuma, 2024. [PDF]

Epidemiol Serv Saude
Lopes BT, Oliveira CH, Souza PAA, Cordeiro-de-Barros RM, Teixeira TJ, Santos RMD, Menezes ASDS, Abreu FVS.   +7 more
europepmc   +1 more source

Impact of COVID-19 on the incidence of visceral leishmaniasis in children and adolescents in the Northeast region, 2007-2022: time series study. [PDF]

Epidemiol Serv Saude
Santos PHFD, Santos BRRD, Farias KF.
europepmc   +1 more source